The routine commissioning of linaclotide (Constella®) is not accepted in Devon for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults.
| Filename: | Linaclotide (Constella®) for the symptomatic treatment of moderate-to-severe irritable bowel syndrome with constipation (IBS-C) |
| Filetype: | |
| Filesize: | 100.24 KB |
| Date uploaded: | 29th November 2016 |
| Date updated: | 8th December 2022 |
